Despite the fact that bcl-2 does not act directly on cell proliferation, its overexpression enables tumors to progress to highly malignant phenotypes and to become more resistant to chemotherapy and apoptosis-inducing radiation therapy, with subsequent metastatic spread and tumor progression [8,19,20]. Here, BCL2 is linked to neoplasm.